Epigenetics of aging and aging-associated diseases

D Saul, RL Kosinsky - International journal of molecular sciences, 2021 - mdpi.com
Aging represents the multifactorial decline in physiological function of every living organism.
Over the past decades, several hallmarks of aging have been defined, including epigenetic …

[HTML][HTML] Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents

Q Chen, B Yang, X Liu, XD Zhang, L Zhang, T Liu - Theranostics, 2022 - ncbi.nlm.nih.gov
The histone acetyltransferases CBP and p300, often referred to as CBP/p300 due to their
sequence homology and functional overlap and co-operation, are emerging as critical …

The role of CREBBP/EP300 and its therapeutic implications in hematological malignancies

Y Zhu, Z Wang, Y Li, H Peng, J Liu, J Zhang, X Xiao - Cancers, 2023 - mdpi.com
Simple Summary Through their regulatory effects on gene expression, histone
acetyltransferases have been implicated in the normal physiological activities and genesis …

Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies

NL Michmerhuizen, JM Klco… - Blood, The Journal of …, 2020 - ashpublications.org
Abstract Nucleoporin 98 (NUP98) fusion oncoproteins are observed in a spectrum of
hematologic malignancies, particularly pediatric leukemias with poor patient outcomes …

MYC—master regulator of the cancer epigenome and transcriptome

CJ Poole, J Van Riggelen - Genes, 2017 - mdpi.com
Overexpression of MYC is a hallmark of many human cancers. The MYC oncogene has long
been thought to execute its neoplastic functions by acting as a classic transcription factor …

Effects of the acetyltransferase p300 on tumour regulation from the novel perspective of posttranslational protein modification

Q Zeng, K Wang, Y Zhao, Q Ma, Z Chen, W Huang - Biomolecules, 2023 - mdpi.com
p300 acts as a transcription coactivator and an acetyltransferase that plays an important role
in tumourigenesis and progression. In previous studies, it has been confirmed that p300 is …

Peptidomimetic blockade of MYB in acute myeloid leukemia

K Ramaswamy, L Forbes, G Minuesa, T Gindin… - Nature …, 2018 - nature.com
Aberrant gene expression is a hallmark of acute leukemias. MYB-driven transcriptional
coactivation with CREB-binding protein (CBP)/P300 is required for acute lymphoblastic and …

[HTML][HTML] Recent advances in the understanding and treatment of acute myeloid leukemia

J Watts, S Nimer - F1000Research, 2018 - ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease that
has a poor prognosis. Recent advances in genomics and molecular biology have led to a …

Epigenetics in myelodysplastic syndromes

M Heuser, H Yun, F Thol - Seminars in cancer biology, 2018 - Elsevier
Epigenetic regulators are the largest group of genes mutated in MDS patients. Most mutated
genes belong to one of three groups of genes with normal functions in DNA methylation, in …

Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia

S Takao, L Forbes, M Uni, S Cheng, JMB Pineda… - Elife, 2021 - elifesciences.org
Dysregulated gene expression contributes to most prevalent features in human cancers.
Here, we show that most subtypes of acute myeloid leukemia (AML) depend on the aberrant …